Microbix products face potential 50% US tariffs on Canadian imports
Bitget2026/10/28 11:11- Microbix is reviewing 50% U.S. tariffs on Canadian products taking effect at 12:01 a.m. on October 30, 2026.
- QAPs products appear covered by tariffs targeting diagnostic and laboratory reagents; U.S. buyers or importers will pay the duties.
- QAPs generated C$ 4.2 million over nine months through June 30, 2026, including C$ 3.4 million from U.S. clients.
- Total revenue from U.S. clients reached C$ 5.5 million over the same period.
- Persistent tariffs could prompt U.S. customers to seek cost-sharing or domestic suppliers, despite validation requirements limiting ready substitutes for QAPs.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Lithium-For-Earth Raises KRW 1.32 Billion in Private Placement
Anthropic "accidentally" leaks IPO documents! Plans to raise $69.3 billion, valuation drops from 2 trillion to 1.3 trillion
Anthropic mistakenly published and then withdrew a prospectus for a planned $69.3 billion fundraising, with its valuation dropping from a peak of $2 trillion to between $1.1 trillion and $1.3 trillion.
Subaru Publishes Transcript of First-Half FYE 2027 Financial Results Presentation
Citi: Occidental Petroleum (OXY.US) Q3 cash flow surpasses expectations, accelerated debt repayment cannot hide concerns over Q4 output
Citi published a research report maintaining Occidental Petroleum's "Neutral" rating, with a target price of $65.